Tevogen Bio Holdings Inc.
TVGN
$0.9922
-$0.0178-1.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -160.02% | -50.68% | 56.44% | 136.63% | 36.57% |
| Total Depreciation and Amortization | 2.58% | 8.65% | 7.87% | 7.79% | -48.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 383.20% | 97.87% | -73.97% | -152.21% | -50.34% |
| Change in Net Operating Assets | -999.85% | -366.25% | 1,191.58% | 827.96% | 85.64% |
| Cash from Operations | -54.20% | -111.37% | -34.50% | 0.61% | 27.78% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -100.00% | -13.04% | -- | -- | -86.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 100.00% | -- | -- | -- |
| Cash from Financing | 373.60% | 426.32% | -- | -2.83% | -83.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.59% | 240.62% | 91.77% | 39.81% | -286.42% |